BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for Alinity m SARS-CoV-2 Amplification Reagent Kit Kit, Alinity m Resp-4-Plex Amplification Reagent Kit, Alinity m SARS-CoV-2 Amplification Reagent Kit Emergency Use Authorization (EUA) and Alinity m Resp-4-Plex Amplification Reagent by Abbott Molecular, Inc

2022.06.09

Product group In-vitro diagnostics - microbiological products
Reference 19385/21

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for Alinity m SARS-CoV-2 Amplification Reagent Kit Kit, Alinity m Resp-4-Plex Amplification Reagent Kit, Alinity m SARS-CoV-2 Amplification Reagent Kit Emergency Use Authorization (EUA) and Alinity m Resp-4-Plex Amplification Reagent by Abbott Molecular, Inc , Download_VeroeffentlichtAm_EN PDF, 748KB, File does not meet accessibility standards